Raia Drogasil releases 2Q26 earnings presentation
Reuters2026/08/05 13:29- Raia Drogasil published its 2Q26 earnings presentation, reporting gross revenue of R$ 12.8 billion, up 18.3%, with MSSS up 10.9%.
- Adjusted EBITDA totaled R$ 1.02 billion, up 17.9%, with an 8% margin; adjusted EBT was R$ 543 million, up 33.4%.
- Adjusted net income was R$ 433 million, up 7.4%, with a 3.4% margin; free cash flow reached R$ 550 million.
- National retail market share rose to 19.7%, up 1.7 pp; digital sales were R$ 3.9 billion, up 55.2%, with 31% penetration.
- Financial leverage stood at 0.8x net debt to EBITDA; pharmacies in operation totaled 3,687, with 53 million active customers.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
10-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
